Covered recipient · General Payments record
HEATHER R BAUM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,952.22
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,252.64 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $282.62 | 10 |
| Amgen Inc. | $145.79 | 1 |
| bioMerieux | $143.00 | 1 |
| Phathom Pharmaceuticals, Inc. | $126.20 | 1 |
| Novo Nordisk AS | $125.00 | 1 |
| GlaxoSmithKline, LLC. | $122.09 | 1 |
| Acerta Pharma LLC | $112.21 | 1 |
| ABBVIE INC. | $99.40 | 1 |
| Averitas Pharma Inc. | $96.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $99.40 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106496969 | CMS |
| Amgen Inc. | $145.79 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117503110 | CMS |
| AstraZeneca Pharmaceuticals LP | $112.21 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105686771 | CMS |
| Averitas Pharma Inc. | $96.33 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133453198 | CMS |
| bioMerieux Inc | $143.00 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147100234 | CMS |
| GlaxoSmithKline, LLC. | $122.09 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116371211 | CMS |
| Lilly USA, LLC | $1.93 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135697216 | CMS |
| Lilly USA, LLC | $3.78 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135679161 | CMS |
| Lilly USA, LLC | $125.00 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135652339 | CMS |
| Lilly USA, LLC | $124.00 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135697214 | CMS |
| Lilly USA, LLC | $4.02 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135697218 | CMS |
| Lilly USA, LLC | $14.02 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135697220 | CMS |
| Lilly USA, LLC | $1.06 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135678213 | CMS |
| Lilly USA, LLC | $2.63 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135688642 | CMS |
| Lilly USA, LLC | $4.53 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135652337 | CMS |
| Lilly USA, LLC | $1.65 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135676709 | CMS |
| Novo Nordisk Inc | $125.00 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100349968 | CMS |
| Phathom Pharmaceuticals, Inc. | $126.20 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151147772 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.